Anavo Therapeutics Appoints Edward Holson As CSO And President US
09 Oct 2024 //
BUSINESSWIRE
Anavo Therapeutics Strengthens Management Team
21 Sep 2023 //
BUSINESSWIRE
Anavo Therapeutics extends Seed Round to EUR 28 Million
02 May 2023 //
BUSINESSWIRE
Anavo Therapeutics Strengthens Scientific Advisory Board
26 Jun 2021 //
BUSINESSWIRE